Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion.

Alexia Rouland Benjamin BouilletPauline LegrisIsabelle SimoneauJean-Michel PetitBruno Vergès

Published in: Clinical pharmacology : advances and applications (2021)

We present the first case of nesidioblastosis treatment with pasireotide LAR, with success. Patients diagnosed with nesidioblastosis and diazoxide-resistant hypoglycemia, or who experience difficulties with other treatments, could use pasireotide LAR in conjunction with glycemia monitoring, particularly if they are diabetic.

Keyphrases

type diabetes
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
case report
glycemic control
patient reported outcomes
metabolic syndrome
adipose tissue
insulin resistance